Medtronic (NYSE: MDT), the US-Irish medical technology giant, has announced that it has received approval from Chinese authorities for its fully upgraded Mazor X spinal surgery robot integrated platform. This marks a significant milestone for the company’s advanced surgical solutions in the Chinese market.
Initially launched in China in 2021, the updated Mazor X platform now offers enhanced global foresight, precision throughout the surgical process, and comprehensive dimensional visibility. The product is equipped with Medtronic’s state-of-the-art navigation visualization high-speed power grinding system, designed to minimize operational errors associated with cone rotation during surgery. This innovation allows for precise visual cutting of bone structures.
Furthermore, the system integrates advanced visual intervertebral space processing and intervertebral fusion operation modules. These features contribute to a more minimally invasive surgical approach, reducing soft tissue damage and enhancing patient outcomes.- Flcube.com
